The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for seniors. Carina Marquez, MD, associate professor of Medicine in ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

RSV vaccines effective, but more people need to get them Date: October 28, 2024 Source: University of Rochester Medical Center Summary: Doctors detail what we learned after the first season ...

Wisconsin health officials are urging state residents to get their flu, COVID-19 and RSV vaccines now. To date, only 17% of ...

All RSV vaccines are currently given as a single dose ... For the COVID vaccines, the full price is about $120. If you don’t ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

There are vaccines to protect against RSV: There are vaccines for older adults and pregnant women (to protect their babies). There's also a shot for babies. People are less worried about RSV now ...

In clinical studies, the Arexvy vaccine against RSV provided good protection against ... falling to 57% by 120-180 days. The evaluation is only based on adults aged 65 and over who were eligible ...

the respiratory syncytial virus (RSV) vaccine mResvia, in May 2024. Moderna hopes to win 10 additional product approvals through 2027. The first of these could be for its next-generation COVID ...